SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607950. A total of 6 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,491,526 | +138.2% | 78,300 | +125.0% | 0.00% | – |
| Q2 2023 | $3,985,296 | -19.7% | 34,800 | -3.3% | 0.00% | -100.0% |
| Q1 2023 | $4,962,000 | +510393.8% | 36,000 | +380.0% | 0.00% | – |
| Q4 2022 | $972 | -99.9% | 7,500 | -17.6% | 0.00% | – |
| Q3 2022 | $1,006,000 | -87.1% | 9,100 | -90.9% | 0.00% | -100.0% |
| Q1 2022 | $7,812,000 | -50.0% | 100,000 | -42.4% | 0.00% | -50.0% |
| Q4 2021 | $15,624,000 | -55.9% | 173,500 | -54.7% | 0.00% | -50.0% |
| Q3 2021 | $35,411,000 | -50.3% | 382,900 | -8.3% | 0.00% | -60.0% |
| Q4 2020 | $71,197,000 | +19299.7% | 417,600 | +15961.5% | 0.01% | – |
| Q3 2020 | $367,000 | -94.0% | 2,600 | -94.5% | 0.00% | -100.0% |
| Q4 2019 | $6,142,000 | +60.4% | 47,600 | +61.4% | 0.00% | 0.0% |
| Q2 2019 | $3,828,000 | -11.5% | 29,500 | -18.7% | 0.00% | 0.0% |
| Q1 2019 | $4,327,000 | +46.8% | 36,300 | +34.4% | 0.00% | 0.0% |
| Q4 2018 | $2,947,000 | -58.5% | 27,000 | -38.6% | 0.00% | 0.0% |
| Q3 2018 | $7,106,000 | -73.4% | 44,000 | -78.2% | 0.00% | -80.0% |
| Q2 2018 | $26,700,000 | +460.7% | 202,000 | +100.0% | 0.01% | +400.0% |
| Q3 2017 | $4,762,000 | – | 101,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 962 | $16,401,000 | 0.61% |
| GROUP ONE TRADING, L.P. | 183,600 | $31,302,000 | 0.05% |
| SIMPLEX TRADING, LLC | 950 | $16,196,000 | 0.02% |
| JPMORGAN CHASE & CO | 417,600 | $71,197,000 | 0.01% |
| IMC-Chicago, LLC | 33,800 | $5,763,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |